Navigation Links


HIV at Biology News

Topical treatment shown to inhibit HIV and herpes simplex virus infection

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina. The study, which was fund...

Elusive HIV shape change revealed; Key clue to how virus infects cells

Structural biologists at Children's Hospital Boston and Harvard Medical School have shown how a key part of the human immunodeficiency virus (HIV) changes shape, triggering other changes that allow the AIDS virus to enter and infect cells. Their findings, published in the Feb. 24 issue of the journal Nature, offer clues that will help guide vaccine and treatment approaches. Researchers led...

Research advances quest for HIV-1 vaccine

Scientists have uncovered new information that may help guide design of vaccines for HIV-1, the virus that causes AIDS. A new detailed structural analysis of the complex formed by an anti-HIV antibody called 4E10 and its specific target provides insight into why this particular antibody is so broadly effective, a rare characteristic for HIV discovered thus far. The research is published in the Fe...

Male circumcision reduces risk of HIV transmission from women to men

The first study to examine the probability ofHIV infection per act of heterosexual sex among a population withmultiple sexual partners has found that uncircumcised men have morethan twice the risk of acquiring HIV than do circumcised men.In the study, published in the Feb. 15 issue of The Journal ofInfectious Diseases, now available online, Jared Baeten and colleaguesfrom the United States...

A much-needed shot in the arm for HIV vaccine development

International efforts towards developing avaccine against HIV infection have been given a much-needed boost bythe publication today of the Global HIV/AIDS Vaccine Enterprise'sscientific strategic plan, published online in the freely available,open-access global health journal PLoS Medicine.The Global HIV/AIDS Vaccine Enterprise is an international alliance ofindependent agencies and organiz...

More>>

HIV at Biology Products

HIV-1 p24 ELISA Kit, Alliance (480 Tests) from PerkinElmer

Description:The PerkinElmer kit provides reagents for immune complex disruption (ICD) of antigen/antibody complexes in serum and plasma samples using a combination of low pH and heat. The samples are then neutralized and transferred to microplate wells which are coated with a highly specific mouse monoclonal antibody to HIV-1 p24. The immobilized monoclonal antibody captures both free HIV-1 p24 and that whic...
Company:PerkinElmer

HIV RT from Chimerx

Description:HIV Reverse Transcriptase provides an excellent target for evaluating antiviral agents or catalyzing error prone synthesis on RNA and DNA templates....
Company:Chimerx

PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts) from Arcturus, now part of Molecular Devices

Description:Laser Capture Microdissection (LCM) enables you to dramatically increase the sensitivity and accuracy of molecular assays by starting with samples of homogeneous cell types and multi-cellular structures isolated from whole tissue or cytology samples. This unique approach to microdissection-developed in 1996 at the National Institutes of Health and availa...
Company:Arcturus, now part of Molecular Devices

PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices

Description:Laser Capture Microdissection (LCM) enables you to dramatically increase the sensitivity and accuracy of molecular assays by starting with samples of homogeneous cell types and multi-cellular structures isolated from whole tissue or cytology samples. This unique approach to microdissection-developed in 1996 at the National Institutes of Health and availa...
Company:Arcturus, now part of Molecular Devices

HIV Volume 2 (Biochemistry, Molecular Biology and Drug Discovery) from Promega

Description:J. Karn (1995) This volume provides excellent background information, detailed practical information and methods for the study of major HIV proteins including: the HIV growth cycle; reverse transcriptase, ribonuclease H, integrase and protease. Expression of HIV proteins using baculoviruses; RNA binding assays; Tat and Rev assays; HIV/CD4 interactions; transient assays for Nef-induced down regu...
Company:Promega

More>>

HIV at Biology Technology

Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue

In situ Adapter for the RoboCycler 40 Temperature Cycler allows rapidamplification of rare mRNA Department of Medicine, University of Illinois at Chicago Figure 1: RoboCycler 40 Temperature Cycler In Situ Adapter Syst...

Recombinant HIV Reverse Transcriptase

Ideal for reverse transcribing transcripts with high G/C content...

MailFoundry introduces new e-mail archive product

Businesses large and small now are using e-mail archives as tactical tools to address human resource issues, customer-relations management, and data recovery in the event of a lost laptop or a crashed hard drive. With their multi-faceted functionality...

EraGen collaborates with Emory University on HIV detection system

MADISON - to develop a quantitative genotyping system useful in the early detection of the HIV variants. The partnership is supported by an NIH STTR g...

Studies Offer New Insight into HIV Vaccine Development

MADISON-Mutations that allow AIDS viruses to escape detection by the immune system may also hinder the viruses' ability to grow after transmission to new hosts, scientists at the University of Wisconsin-Madison announced this week in the journal Nature Medicine. The discovery may help researchers design vaccines that exploit the notorious mutability of HIV by training the immune system t...
HIV at Medicine News

Patients With Filariasis More Prone To HIV Infection

According to a report published in the December issue of the Journal of Infectious Diseases, HIV infection is significantly enhanced in peripheral blood mononuclear cells (PBMCs) from individuals with untreated filarial infection compared to PBMCs from infected patients treated with antifilarial agents. According to Dr. Ramya Gopinath and her team at the National Institute of Allergy and...

International community warns India on HIV situation

The International Community has warned India that it is time to treat the HIV situation as a national emergency. Experts attending the Peoples Health Assembly at Dhaka, Bangladesh , have cautioned India not to be complacent about the looming HIV crisis in the country. Rebuffing the optimistic statement of Union Health Minister, Dr.C.P.Takhur, the experts said if corrective measures are no...

Debate Rages over firing of HIV infected health care workers

When we flip through the news papers it isn’t uncommon for us to see news items which tell us that an employee has been fired from an establishment after testing positive for HIV. But rarely do these matters become a major controversy when many sit up and take notice. Especially in the health care industry people don’t bat an eyelid when someone is fired because of ones HIV serostatus. Ma...

HIV infected patients can travel safely abroad

Many HIV infected patients, apart from suffering the social neglect and being unwanted even by near and dear ones have this major handicap - they just can’t travel like the other people - wherever they want and whenever they want. Some people just avoid having HIV infected co passengers. Others are just indifferent. Leaving the ethical issues aside, it is very difficult for these victims...

Man against HIV – new vaccine ready for human trials

A new vaccine called the TAT vaccine has been developed in Italy as the latest and most exciting HIV vaccine to date. And more importantly it has had a 71% success rate when tested on monkeys. This vaccine is now ready for human testing and this may be the brightest hope for mankind against the destructive HIV. Dr.Barbara Ensoli, Head of the Department of Virology at Italy’s National Hea...

More>>

HIV at Medicine Products

Centricity Cardiology- Image Management and Archive

Description:GE's complex Cath Lab solution enhances your productivity and workflow efficiency across your department, your facility and your entire enterprise....
Company:GE Healthcare

Beehive Millennium - Long-term Epilepsy Monitoring

Description:Beehive Millennium, the newest entry in the Beehive product line, combines decades of experience in epilepsy monitoring with the technology of the 21st century. Beehive Millennium is a powerful Windows-based digital Video/EEG instrument, providing complete data acquisition, recording and review capabilities that are specialized for epilepsy monitoring applications. Beehive Millennium features ult...
Company:Grass Technologies

OraSure HIV-1 Oral Specimen Collection Device

Description:Testing with an OraSure HIV-1 Oral Specimen Collection Device is a safe, easy, and reliable way to test for HIV-1 antibodies. Testing with the OraSure HIV-1 Oral Specimen Collection Device requires no blood or needles and has been shown to be more than 99% accurate. OraSure HIV-1 uses a specially treated cotton fiber pad attached to a nylon stick which is placed between the lower cheek and gu...
Company:OraSure Technologies, Inc.

OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

Description:The OraQuick ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingerstick whole blood, venipuncture whole blood, and plasma specimens....
Company:Abbott Diagnostics

Uni-Gold Recombigen HIV

Description:Rapid Immunoassay: Uni-Gold Recombigen HIV is a single use rapid test, for the detection of antibodies to HIV-1 in plasma, serum and whole blood (venipuncture). Uni-Gold Recombigen HIV is intended for use in point of care settings as an aid in diagnosis of infection with HIV-1. This test is suitable for use in appropriate multi-test algorithms designed for the statistical validation of rapid HIV...
Company:Trinity Biotech

More>>

HIV at Medicine Technology

Rapid HIV Testing Increases Possibility of Treatment

According to a November, 2005 joint press release from UNAIDS (Joint United Nations Programme on HIV/AIDS) and the World Health Organization, the number of people living with HIV globally reached an estimated high of 40.3 million people in 2005, with over 3 million deaths caused by AIDS. The latest data from...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

Data Published in The Lancet on TMC125, an Investigational NNRTIfrom Tibotec YARDLEY, Pa., July 05, 2007 /PRNewswire/ -- Data from twoongoing Phase 3 studies (DUET-1 and DUET-2) showed significantlymore HIV-1 adult patients with documented non-nucleoside reversetranscriptase inhibitor (NNRTI) and protease inhibitor (PI)resistance reached an undetectable viral load (defined as achievingco...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

BRIDGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Results fromthe primary analysis of a randomized, controlled, open-label, Phase3 study showed that 77 percent of treatment-experienced HIV-1infected adults taking PREZISTA(TM) (darunavir) 600 mg tablets with100 mg ritonavir (PREZISTA/r) twice daily, plus an optimizedbackground regimen (OBR) of antiretroviral (ARV) agents, reached aplasma v...

New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV

Phase III clinical trial provides hope that HIV patients can livelonger lives PASADENA, Calif., July 05, 2007 /PRNewswire/ -- A newinvestigational drug used in combination with a second newer agenthas proven to be effective in fighting drug-resistant HIV,according to a Lancet article to be published in its July 7thspecial HIV/AIDS issue. The multinational phase III clinical trial,...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

MONTREAL, QUEBEC--(CCNMatthews - June 14, 2007) - AmbriliaBiopharma Inc. (TSX:AMB), a biopharmaceutical company developingnovel small molecules and peptides to treat infectious diseases andcancer, held its Annual General and Special Meeting today, duringwhich the data reported yesterday on its novel series of HIVintegrase inhibitors and recent developments were highlighted. Themeeting wa...

More>>

HIV at Medicine Dictionary

Hiv infection

(<a href="/ ?q=/ Medicine-Dictionary/ hiv"...

Hives

s (wheals) of the <a href="/ ?q=/ Medicine-Dictionary/ s...

HIV

H...

Asymptomatic HIV infection

<a href=...

Acute HIV infection

that gradually destroys the <a href=...
Other TagsBurrBurrPhacoemulsificationIrisIrisOlkOlkGawaChop
(Date:5/16/2008)...delines quickly disseminated to community physicia...thDay News) -- Partnerships between major academic...k and effective way to spread cancer treatment adv...in Philadelphia. , Most new cancer treatments a...er care is provided at community hospitals, noted ...
(Date:5/16/2008)...in some early stage cases makes therapy of little ...ay 16 (HealthDay News) -- Colon cancer patients wi...receive chemotherapy. In fact, not only does chemo... actually harm them, a new study found. , "If yo...hen you should not be treated with chemotherapy. S...
(Date:5/16/2008)...a., May 16 /PRNewswire-USNewswire/ -- The Centers ...gency for Toxic Substances and,Disease Registry (A...,Health Improvement Award for 2008. Since its 1999... Stockpile (DSNS) in the CDC Coordinating Office,f...with LMI,s Health,Systems Management group, supple...
(Date:5/16/2008)... scheduled for Pittsburgh Zoo & PPG Aquarium for M...r Life, the Medicare product,of UPMC Health Plan, ...ual,National Senior Health & Fitness Day, which ha....", National Senior Health & Fitness Day is sched...will serve as host for three events in,Pennsylvani...
Breaking Medicine News(10 mins):Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2Health News:UPMC for Life is Pennsylvania Sponsor for National Senior Health & Fitness Day 2
(Date:5/14/2008)...,, A vast array of physical and biological ...ming temperatures caused by humans, says a new ana...in one spot. The effects on living things include ...ons; movements of species to higher latitudes and ...ird migrations in Europe, North America and Austra...
(Date:5/14/2008)..., ANN ARBOR, Mich.---Researchers have developed w...rly 20 years for inhibiting a common target used t...ead to a new class of AIDS drugs. , Researchers ... to develop the inhibiting compound, and then conf...ibit HIV protease, which is an established target ...
(Date:5/14/2008)..., Communities of Oregon white oak were once wides...but, today, they are in decline. Fire suppression,... use change have resulted in the loss of as much a...resent in some areas of the region. , A new tech...natives for Managing Oak at Tenalquot Prairie, Was...
(Date:5/14/2008)..., More than 1,400 of the world,s top experts on e...24 for "Evolution 2008," the world,s largest annua...ence, the premier international event for scientis...sored by the University of Minnesota,s Bell Museum...iological Sciences and Minnesota Citizens for Scie...
Breaking Biology News(10 mins):Warming climate is changing life on global scale, says new study 2Compound has potential for new class of AIDS drugs 2University of Minnesota to host world's largest conference on evolution 2Virginias largest Cardiac Surgery program adopts SPY as standard of care 16214 1Virginias largest Cardiac Surgery program adopts SPY as standard of care 16214 2Virginias largest Cardiac Surgery program adopts SPY as standard of care 16214 3Virginias largest Cardiac Surgery program adopts SPY as standard of care 16214 4Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule 16211 1Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule 16211 2Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule 16211 3Tired Mother Invents Pill to Wake You Up On Time 16208 1Tired Mother Invents Pill to Wake You Up On Time 16208 2Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea 28TM 29 for Reducing Post Surgical Pain Following Total Knee Replacement 1704 1Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea 28TM 29 for Reducing Post Surgical Pain Following Total Knee Replacement 1704 2Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea 28TM 29 for Reducing Post Surgical Pain Following Total Knee Replacement 1704 3Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea 28TM 29 for Reducing Post Surgical Pain Following Total Knee Replacement 1704 4
Other Contentslaborlaborlaborlaborlaborlaborlabyrinthitislactaselabyrinthlactationlactationlacticlacticlacticlacticlacticlacticlacticlacerationlacerationintoleranceintoleranceintolerance